Bluejay Diagnostics, Inc. operates as a medical diagnostics company. It offers Symphony technology platform which consists of an analyzer and single-use protein detection cartridges that are designed to provide measurements of key diagnostic biomarkers found in blood; and Symphony analyzer used to orchestrate sample processing of whole blood, plasma, serum, etc., biomarker isolation, and immunoassay preparation using non-contact centrifugal force. The company also develops Symphony IL-6 tests for the monitoring of disease progression in critical care settings. In addition, it develops additional tests for Symphony, such as tests for myocardial infraction and congestive heart failure, as well as other tests using the Symphony platform. Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts.
Frequently asked questions
What sector does Bluejay Diagnostics Inc (BJDX) operate in?
Bluejay Diagnostics Inc belongs to the Healthcare sector and operates in the Medical Devices industry.
What is Bluejay Diagnostics Inc (BJDX) current stock price?
As of the latest data, Bluejay Diagnostics Inc stock price is $1.02, with a previous close of $1.05. Bluejay Diagnostics Inc lost -$0.03 in the last trading session, representing a -2.86% loss.
What is Bluejay Diagnostics Inc (BJDX) current market capitalization?
Bluejay Diagnostics Inc market cap is approximately 1.06 million.
What is Bluejay Diagnostics Inc (BJDX) Earnings Per Share (EPS)?
The trailing EPS is -$3.74.
What is Bluejay Diagnostics Inc (BJDX) EBITDA?
Bluejay Diagnostics Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -2.32 million.
Does Bluejay Diagnostics Inc (BJDX) pay dividends?
No. Bluejay Diagnostics Inc does not pay a dividend.
What is Bluejay Diagnostics Inc (BJDX) beta (volatility) score?
Bluejay Diagnostics Inc has a beta of 0.889, meaning its volatility is roughly in line with the market.
